InfuSystem to Report First Quarter 2024 Financial Results on May 9, 2024

Rhea-AI Summary

InfuSystem Holdings, Inc. (NYSE American: INFU) will report first quarter 2024 financial results on May 9, 2024. The company will conduct a conference call at 9:00 a.m. Eastern Time to discuss the results. InfuSystem is a leading national health care service provider, offering outpatient care for durable medical equipment manufacturers and health care providers.

Investor Conference Call to be held 9:00 a.m. Eastern Time

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)-- InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue first quarter 2024 financial results on Thursday, May 9, 2024, before the market opens.

The Company will also conduct a conference call for all interested parties on Thursday, May 9, 2024 at 9:00 a.m. Eastern Time to discuss its financial results.

To participate in this call, please dial (800) 285-6670 or (713) 481-1320, or listen via a live webcast, which is available in the Investors section of the Company’s website at https://ir.infusystem.com/. A replay of the call will be available by visiting https://ir.infusystem.com/ for the next 90 days or by calling (888) 556-3470, replay access code 159874 through Thursday, May 16, 2024.

About InfuSystem Holdings, Inc.

InfuSystem Holdings, Inc. (NYSE American: INFU), is a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The lead platform is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient Services segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device Solutions segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Headquartered in Rochester Hills, Michigan, the Company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas and Ontario, Canada.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240502251210/en/

Joe Dorame, Joe Diaz & Robert Blum

Lytham Partners, LLC

602-889-9700

Source: InfuSystem Holdings, Inc.

FAQ

When will InfuSystem report its first quarter 2024 financial results?

InfuSystem will report its first quarter 2024 financial results on May 9, 2024.

What is the stock symbol for InfuSystem?

The stock symbol for InfuSystem is INFU.

Where can I listen to the conference call discussing the financial results?

You can participate in the conference call at 9:00 a.m. Eastern Time on May 9, 2024, by dialing (800) 285-6670 or (713) 481-1320, or listen via a live webcast available on the Investors section of the Company’s website at https://ir.infusystem.com/.

What segments does InfuSystem operate under?

InfuSystem operates under two segments: Patient Services, which includes Oncology, Pain Management, and Wound Therapy businesses, and Device Solutions, which supports the Patient Services platform.

Where is InfuSystem headquartered?

InfuSystem is headquartered in Rochester Hills, Michigan, and operates Centers of Excellence in various locations across the United States and Canada.